decisionhealth Newsletters, Coder Pink Sheets - 2015 Issue 7 (July)
New coding guidance: Stop using J codes for compound drugs, new Q code ends compound confusion
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS update affecting how compounded drugs are reported under HCPCS, including the move to a new Q code for unclassified compounded drugs and the phase-out of several older J-code options in this context. It is relevant to billing staff, coders, pharmacy-related providers, and reimbursement teams who need to monitor payer behavior, claim edits, and implementation timing for the change.
Why This Topic Matters
It helps readers understand a reporting change that can affect drug claims, payer acceptance, and denial patterns. The article is especially useful for teams that need to align charge capture and claims workflows with CMS guidance and private payer implementation.
What You Will Learn
- What CMS changed for reporting compounded drugs
- Which general HCPCS reporting approach the article discusses
- How payer implementation may affect claims processing
- What to monitor when claims are denied under older reporting patterns
Who Should Read This
- Medical coders
- Billing staff
- Pharmacy billing teams
- Revenue cycle staff
- Providers handling compounded drug claims
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com